FIELD: medicine.
SUBSTANCE: group of inventions concerns medicine, namely to dermatology, and allows to treat various forms of psoriasis. Versions of the way include introduction of thymodepressin. And at the progressing form of psoriasis thymodepressin is administered in the form of monotherapy intramusculary on 2.0 ml within 7 days, then on 1.0 ml within 7 days daily and the next 14 days in an intranasal manner. At the fixing torpid form of psoriasis thymodepressin is administered intramusculary on 1.0 ml once a day within 14 days, the next 14 days - in an intranasal manner. And at the complicated form of psoriasis thymodepressin is administered intramusculary on 2.0 ml once a day within 14 days, then 14 days - in an intranasal manner. As a result of use of versions of the way therapeutic efficiency of treatment increases at the progressing, fixing torpid and complicated forms of psoriasis and remission terms are enlarged.
EFFECT: increase of therapeutic efficiency of treatment at the progressing, fixing torpid and complicated forms of psoriasis and augmentation of terms of remission.
3 cl, 3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PSORIATIC ERYTHRODERMA | 2011 |
|
RU2496498C2 |
WAY OF TREATMENT OF ATOPIC DERMATITIS | 2007 |
|
RU2361604C1 |
METHOD FOR TREATMENT OF HEAVY FORMS OF PSORIASIS | 2016 |
|
RU2620552C1 |
METHOD OF CURE FOR ERYTHRODERMA PSORIATICUM | 2008 |
|
RU2369394C1 |
METHOD OF TREATING PSORIASIS | 2012 |
|
RU2500443C1 |
METHOD OF PSORIASIS VULGARIS TREATMENT | 2007 |
|
RU2349338C1 |
METHOD FOR TREATING PSORIASIS | 2006 |
|
RU2322255C1 |
METHOD OF TREATING PATIENTS WITH PSORIASIS IN PROGRESSING STAGE | 2019 |
|
RU2716617C1 |
METHOD OF TREATING PSORIASIS | 2009 |
|
RU2394575C1 |
METHOD OF TREATING PATIENTS WITH PSORIASIS IN PROGRESSING STAGE | 2019 |
|
RU2716616C1 |
Authors
Dates
2009-07-20—Published
2007-08-01—Filed